By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

They say April showers bring May flowers, but in this case, March preparations in the Blount Memorial Cancer Center bring a new treatment option for prostate cancer patients in April. Men with ...

After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once will face a recurrence within five years. A new treatment, known as salvage ...

A 76-year-old man underwent retropubic prostatectomy for obstructive symptoms 10 years ago. He now presents with newly diagnosed prostate carcinoma, Gleason score 4 (2+2), PSA 8.2, stage T1c, prostate ...

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Johnson & Johnson (JNJ) reported late-stage clinical trial results showing that adding its prostate cancer drug apalutamide to hormone therapy before and after surgery improved outcomes for men with ...